SY

Healthcare · Pharmaceuticals

Syncom Formulations (India) Ltd (SYNCOMF)

₹21.90

Mkt cap
₹2,059 Cr
P/E ratio
22.00
P/B
4.42
Div yield
0.46%
ROE
17.60%
ROCE
24.80%
EPS (TTM)
₹1.00
Book value
₹5
52W range
10–27
Sector
Healthcare

Price history

Previous close

Established in the year 1995, Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products. The company is a generic pharmaceutical player operating in more than 15 countries worldwide having more than 400 products registered. [1]

NSE SYNCOMFBSE 524470
Health check
Constructive
ValuationCheap
ProfitabilityStrong
GrowthModerate
TechnicalsBullish
52-week range
−20.33% from high
₹22
₹10+114.50% from low₹27
Current
₹21.90
Prev close
₹22.09
Day
−0.86%
Price performance
1D
−1.31%
1W
+7.44%
1M
−1.27%
3M
+41.01%
6M
+52.88%
1Y
+31.48%
YTD
+51.45%

Financials

Revenue, profit & margin
P/E ratio
22.0×
SYNCOMF is 32% below the sector median of 32.5×
SYNCOMF22.0×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales62637387101127148117121115134125137
YoY Sales growth+14%+10%+19%+46%+63%+101%+103%+34%+20%-10%-10%+7%+13%
Expenses56576476901121311011039311399106
Operating Profit67910121517161921212630
OPM %10%11%12%12%12%11%12%14%15%18%16%21%22%
Other Income44314476551486
Interest1110000000000
Depreciation1111111111222
Profit before tax89910151723202225333234
Tax %24%25%27%24%25%24%24%22%25%25%25%23%26%
Net Profit6678111318161719252525
EPS in Rs0.070.070.070.080.120.140.190.170.180.200.260.260.27
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +6.86% · closed higher next day 2 of last 2
 Q1FY27Q2FY27
Broadcast11 Aug '26◦13 Nov '26◦
Earnings day+9.29%+4.44%
+1 day+4.89%+2.96%
+5 days+5.51%—
+15 days+47.21%—
+30 days+37.85%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
50.57%Promoter
Promoters50.57%
FIIs2.23%1.88
Public47.20%1.87
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.764,52,2510.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.161,78,3740.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.531,23,9800.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.421,19,7000.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.471,16,1190.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.811,14,3160.92%852−35.05%7,404−2.44%15.49%
Syncom Formul.₹21.9022.042,0590.46%25+50.83%137+12.53%24.78%
Median: 160 Co.₹432.2032.471,9830.08%13+33.73%179+21.23%14.94%

Filings

Announcements5